🇺🇸 FDA
Patent

US 8948863

Photokinetic ocular drug delivery methods and apparatus

granted A61KA61K31/167A61K31/519

Quick answer

US patent 8948863 (Photokinetic ocular drug delivery methods and apparatus) held by The Board of Regents of the University of Texas System expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/167, A61K31/519, A61K31/573, A61K31/58